Maruti Suzuki India (MSI) on Saturday said it will work with AgVa Healthcare to help it rapidly scale up production of ventilators in the country in wake of coronavirus pandemic. “An arrangement has been entered into with AgVa Healthcare, an existing approved manufacturer of ventilators,” MSI said in a statement. The company would work with AgVa Healthcare to rapidly scale up production of ventilators with intention of reaching a volume of 10,000 units per month, it added. As per the arrangement, AgVa Healthcare will be responsible for the technology, performance and related matters for all the ventilators produced and sold by them, MSI said. The auto major on its part will use its suppliers to produce the required volume of components and use its experience and knowledge to upgrade systems for the production and quality control of the higher volumes, it added. MSI would also help, to the required extent to arrange financing, and obtain all permissions and approvals required to enable the higher production, the auto major said. The company would provide these services free of cost to AgVa Healthcare, it added. Besides, Krishna Maruti Limited, a joint venture of MSI with Ashok Kapur, will be manufacturing 3-ply masks for supply to Haryana and the central government. Production is expected to start as soon as all approvals are received, MSI said. Kapur will provide 2 million masks free of cost as his own contribution, it added. Similarly, Bharat Seats Limited, a joint venture of MSI with the Relan family, would be manufacturing protective clothing as soon as all approvals are in place. All manufacturing units will take maximum care to protect the safety and health of the workers in accordance with the government recommended practices, it added. Already Mahindra & Mahindra (M&M) has announced that it expects to come up with a sophisticated ventilator at just Rs 7,500, which otherwise costs up to Rs 10 lakh. Tata Motors also plans to come up with manufacturing of ventilators.
Sun Pharmaceutical’s Announcements
Sun Pharmaceutical Industries Ltd has committed to donate Rs 25 crore worth of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitisers to support India’s fight against coronavirus pandemic, according to a company statement. The national task force for COVID-19 constituted by Indian Council of Medical Research has recommended HCQS as prophylaxis of the infection for high risk population. HCQS is being studied by the World Health Organization (WHO) for use in conjunction with Azithromycin to treat COVID-19. “The company is committed to working closely with the governments and relevant stakeholders to ensure there is uninterrupted supply of medicines,” Sun Pharma said in a statement. The company is constituting a task force to handle the distribution of these products in India, it added. Commending the efforts of the entire medical and support fraternity in fighting COVID-19, Sun Pharma said,”To help these front-line warriors, the company has repurposed its liquid manufacturing facility in India to produce high-quality hand sanitisers.” These will be made available to healthcare professionals serving their communities and the nation, it added. The domestic pharma major also said it has instituted work from home for all team members who are able to work remotely at all its locations.
Hyundai Motor India Foundation (HMIF) Ordering Advanced Diagnostics
Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India, on Saturday said it is ordering advanced diagnostic testing kits for coronavirus infection from South Korea as part of its measures to combat the pandemic. These advanced kits have a very high level of accuracy and can help serve over 25,000 people, Hyundai Motor India Ltd ( HMIL) said in a statement. “Post receiving the shipment, the kits will be distributed in consultation with the Centre, and state governments to the hospitals in affected areas,” it added. Commenting on the initiative, HMIL MD & CEO SS Kim said, “As part of our global direction – ‘Progress for Humanity’, Hyundai is committed to supporting the Government of India’s spirited fight against the COVID-19 crisis.” He further said, “Our contribution towards supplies of Advanced Diagnostic testing kits will help over 25,000 people.” The company continues to monitor the situation closely and support the Indian government with multi-layered CSR initiatives to bring back normalcy at the earliest, he added. Hyundai has also announced initiatives to support customers in these challenging times. Its 24X7 roadside assistance will be available for customers to ensure help in case any demanding situation arises, the company said. Additionally, customers who were unable to avail vehicle’s warranty/extended warranty/free service due to health emergency or dealership shutdown in affected cities, HMIL will offer extended support of two months, it added